Follow
Myeloma
Myeloma is cancer of the plasma cells. Plasma cells are white blood cells that produce disease- and infection-fighting antibodies in your body. Myeloma cells prevent the normal production of antibodies, leaving your body's immune system weakened and susceptible to infection. The multiplication of myeloma cells also interferes with the normal production and function of red and white blood cells. An abnormally high amount of these dysfunctional antibodies in the bloodstream can cause kidney damage. Additionally, the myeloma cells commonly produce substances that cause bone destruction, leading to bone pain and/or fractures.
-
OCT 03, 2019Cancer
Research published recently in Cell Stem Cell details the results from a new anticancer immunotherapy that uses invarian ...Written By: Kathryn DeMuth SullivanAUG 25, 2019Drug Discovery & Development
According to the findings of a clinical trial, scientists at Mt. Sinai have found a new therapeutic effective for p ...Written By: Nouran AminFEB 04, 2019Cancer
With all of these "new and improved" methods to treat cancer, such as immuno-based, using nanotechnology, to g ...Written By: Amy LoriauxFEB 04, 2019Cancer
In a recent report out of The Lancet: Public Health, published by Dr. Ahmedin Jemal, Ph.D., and colleagues fro ...Written By: Amy LoriauxJAN 21, 2019Genetics & Genomics
Scientists are learning more about how small genetic changes can lead to an increased risk of disease.Written By: Carmen LeitchAUG 07, 2018Cancer
A group of US researchers have identified CD13 in certain subtypes of B-cell neoplasms, thereby aiding in a more detaile ...Written By: Mauri BrueggemanAUG 07, 2018Cancer
Targeted therapy for Bcl-2 may be helpful in more than the two lymphoma diagnoses that were recently approved by the FDA ...Written By: Mauri BrueggemanJUL 03, 2018Cancer
New changes in myeloid classification help to outline a new category of AML which develops as a result of hereditary mut ...Written By: Mauri BrueggemanJUN 05, 2018Cancer
The NCI-MATCH Phase II Clinical Trial is evaluating results of cancer treatments administered based on genetic profiles ...Written By: Mauri BrueggemanMAY 29, 2018Cancer
Obesity, and the factors that lead up the state of being obese, contribute to physiological function; the literature sup ...Written By: Mauri BrueggemanMAY 15, 2018Cancer
Understanding a cancer diagnosis can feel overwhelming for individuals not familiar with medicine and the language used. ...Written By: Mauri BrueggemanMAY 01, 2018Cancer
Researchers have developed a microfluidic device that can detect circulating plasma cells in whole blood; therefore, neg ...Written By: Mauri BrueggemanJAN 01, 2018Cardiology
A drug approved by the FDA in 2012 to treat a type of cancer called multiple myeloma has dangerous side effects that inv ...Written By: Kara MarkerDEC 26, 2017Drug Discovery & Development
Nanoparticles Improve Chemotherapy Via Anti-tumor ImmunityWritten By: Courtney SchaalDEC 17, 2017Drug Discovery & Development
Brief overview of epigenetic therapeuticsWritten By: Courtney SchaalNOV 12, 2017Drug Discovery & Development
Repurposing already approved drugs for new therapeutic indications to expedite new drugs being used in the clinicWritten By: Courtney SchaalOCT 05, 2017Cancer
The link between obesity and cancer just got even more real. A recent report finds that over 40 percent of cancer cases ...JUL 16, 2017Cell & Molecular Biology
NF2 affects thousands of people. New research could help bring treatment to those patients.Written By: Carmen LeitchMAR 16, 2017Health & Medicine
JUPITER, FL – March 16, 2017 – Scientists from the Florida campus of The Scripps Research Institute (TSRI) h ...Written By: The Scripps Research Institute (TSRI)SEP 05, 2016Cancer
Bone marrow transplant patients face many challenges. Even after the success of the transplant procedure, doctors observ ...AUG 29, 2016Cancer
A recent study recently found that being overweight is now linked to 8 more cancers, including stomach and pancreatic ca ...JUL 07, 2016Cancer
When the Human Genome Project was completed in April 2003, scientists around the world rejoiced in the vast amount of da ...JUN 23, 2016Cell & Molecular Biology
The US government panel that evaluates gene therapy trials, the National Institute of Health’s Recombinant DNA Res ...Written By: Carmen LeitchJUN 17, 2016Cell & Molecular Biology
A trial of the CRISPR/Cas9 gene editing technology has been proposed for use in a human patient. The National Institute ...Written By: Carmen Leitch
OCT 03, 2019
Cancer
Research published recently in Cell Stem Cell details the results from a new anticancer immunotherapy that uses invarian
...
Written By:
Kathryn DeMuth Sullivan
AUG 25, 2019
Drug Discovery & Development
According to the findings of a clinical trial, scientists at Mt. Sinai have found a new therapeutic effective for p
...
Written By:
Nouran Amin
FEB 04, 2019
Cancer
With all of these "new and improved" methods to treat cancer, such as immuno-based, using nanotechnology, to g
...
Written By:
Amy Loriaux
FEB 04, 2019
Cancer
In a recent report out of The Lancet: Public Health, published by Dr. Ahmedin Jemal, Ph.D., and colleagues fro
...
Written By:
Amy Loriaux
JAN 21, 2019
Genetics & Genomics
Scientists are learning more about how small genetic changes can lead to an increased risk of disease.
Written By:
Carmen Leitch
AUG 07, 2018
Cancer
A group of US researchers have identified CD13 in certain subtypes of B-cell neoplasms, thereby aiding in a more detaile
...
Written By:
Mauri Brueggeman
AUG 07, 2018
Cancer
Targeted therapy for Bcl-2 may be helpful in more than the two lymphoma diagnoses that were recently approved by the FDA
...
Written By:
Mauri Brueggeman
JUL 03, 2018
Cancer
New changes in myeloid classification help to outline a new category of AML which develops as a result of hereditary mut
...
Written By:
Mauri Brueggeman
JUN 05, 2018
Cancer
The NCI-MATCH Phase II Clinical Trial is evaluating results of cancer treatments administered based on genetic profiles
...
Written By:
Mauri Brueggeman
MAY 29, 2018
Cancer
Obesity, and the factors that lead up the state of being obese, contribute to physiological function; the literature sup
...
Written By:
Mauri Brueggeman
MAY 15, 2018
Cancer
Understanding a cancer diagnosis can feel overwhelming for individuals not familiar with medicine and the language used.
...
Written By:
Mauri Brueggeman
MAY 01, 2018
Cancer
Researchers have developed a microfluidic device that can detect circulating plasma cells in whole blood; therefore, neg
...
Written By:
Mauri Brueggeman
JAN 01, 2018
Cardiology
A drug approved by the FDA in 2012 to treat a type of cancer called multiple myeloma has dangerous side effects that inv
...
Written By:
Kara Marker
DEC 26, 2017
Drug Discovery & Development
Nanoparticles Improve Chemotherapy Via Anti-tumor Immunity
Written By:
Courtney Schaal
DEC 17, 2017
Drug Discovery & Development
Brief overview of epigenetic therapeutics
Written By:
Courtney Schaal
NOV 12, 2017
Drug Discovery & Development
Repurposing already approved drugs for new therapeutic indications to expedite new drugs being used in the clinic
Written By:
Courtney Schaal
OCT 05, 2017
Cancer
The link between obesity and cancer just got even more real. A recent report finds that over 40 percent of cancer cases
...
JUL 16, 2017
Cell & Molecular Biology
NF2 affects thousands of people. New research could help bring treatment to those patients.
Written By:
Carmen Leitch
MAR 16, 2017
Health & Medicine
JUPITER, FL – March 16, 2017 – Scientists from the Florida campus of The Scripps Research Institute (TSRI) h
...
Written By:
The Scripps Research Institute (TSRI)
SEP 05, 2016
Cancer
Bone marrow transplant patients face many challenges. Even after the success of the transplant procedure, doctors observ
...
AUG 29, 2016
Cancer
A recent study recently found that being overweight is now linked to 8 more cancers, including stomach and pancreatic ca
...
JUL 07, 2016
Cancer
When the Human Genome Project was completed in April 2003, scientists around the world rejoiced in the vast amount of da
...
JUN 23, 2016
Cell & Molecular Biology
The US government panel that evaluates gene therapy trials, the National Institute of Health’s Recombinant DNA Res
...
Written By:
Carmen Leitch
JUN 17, 2016
Cell & Molecular Biology
A trial of the CRISPR/Cas9 gene editing technology has been proposed for use in a human patient. The National Institute
...
Written By:
Carmen Leitch